| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Heliogen, Inc. | 10%+ Owner | Common Stock | 442,298 | $672,072 | $1.52 | 15 Feb 2024 | Direct |
| Panbela Therapeutics, Inc. | 10%+ Owner | 8% Senior Convertible Note due 2025 | $12,000,000 | 15 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PBLA | Panbela Therapeutics, Inc. | 15 Nov 2024 | 1 | +$9,150,000 | 4 | 10%+ Owner | 19 Nov 2024, 18:40 |
| PBLA | Panbela Therapeutics, Inc. | 22 Oct 2024 | 0 | $0 | 3 | 10%+ Owner | 29 Oct 2024, 19:38 |
| HLGN | Heliogen, Inc. | 15 Feb 2024 | 1 | +$672,072 | 4 | 10%+ Owner | 20 Feb 2024, 16:51 |
| HLGN | Heliogen, Inc. | 01 Sep 2023 | 1 | +$47,791 | 4 | 10%+ Owner | 06 Sep 2023, 21:12 |
| HLGN | Heliogen, Inc. | 22 Jun 2023 | 1 | +$146,068 | 4 | 10%+ Owner | 26 Jun 2023, 21:51 |
| HLGN | Heliogen, Inc. | 16 Jun 2023 | 3 | +$85,388 | 4 | 10%+ Owner | 21 Jun 2023, 18:16 |
| HLGN | Heliogen, Inc. | 13 Jun 2023 | 3 | +$350,641 | 4 | 10%+ Owner | 15 Jun 2023, 19:31 |
| HLGN | Heliogen, Inc. | 07 Jun 2023 | 3 | +$852,174 | 4 | 10%+ Owner | 09 Jun 2023, 19:45 |
| HLGN | Heliogen, Inc. | 01 Jun 2023 | 2 | +$44,159 | 4 | 10%+ Owner | 05 Jun 2023, 19:21 |
| HLGN | Heliogen, Inc. | 13 Apr 2023 | 1 | +$1,769 | 4 | 10%+ Owner | 17 Apr 2023, 17:18 |
| HLGN | Heliogen, Inc. | 10 Apr 2023 | 3 | +$135,041 | 4 | 10%+ Owner | 12 Apr 2023, 20:06 |
| HLGN | Heliogen, Inc. | 05 Apr 2023 | 2 | +$253,280 | 4 | 10%+ Owner | 10 Apr 2023, 21:21 |
| HLGN | Heliogen, Inc. | 23 Mar 2023 | 2 | +$306,201 | 4 | 10%+ Owner | 27 Mar 2023, 18:55 |
| HLGN | Heliogen, Inc. | 30 Dec 2021 | 2 | $0 | 4 | 10%+ Owner | 05 Jul 2022, 16:47 |
| HLGN | Heliogen, Inc. | 30 Dec 2021 | 0 | $0 | 3 | 10%+ Owner | 05 Jul 2022, 16:45 |
| /report/000089924323018603-nant-capital-llc-2021-04-27 | NantHealth, Inc. | 27 Apr 2021 | 0 | $0 | 3 | 10%+ Owner | 30 Aug 2023, 17:24 |